Name | Number of supported studies | Average coverage | |
---|---|---|---|
microglial cell | 12 studies | 41% ± 15% | |
enterocyte | 4 studies | 21% ± 6% |
Insufficient scRNA-seq data for expression of SLC2A5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 83% | 1066.22 | 2190 / 2642 | 96% | 31.25 | 678 / 705 |
kidney | 85% | 714.43 | 76 / 89 | 80% | 37.33 | 725 / 901 |
prostate | 95% | 1691.32 | 233 / 245 | 45% | 6.41 | 226 / 502 |
intestine | 87% | 1878.30 | 843 / 966 | 32% | 2.98 | 167 / 527 |
ovary | 61% | 317.15 | 110 / 180 | 51% | 3.45 | 219 / 430 |
muscle | 99% | 3056.11 | 794 / 803 | 0% | 0 | 0 / 0 |
spleen | 98% | 928.20 | 237 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 54.26 | 28 / 29 |
skin | 40% | 185.56 | 720 / 1809 | 54% | 5.18 | 255 / 472 |
breast | 51% | 811.68 | 235 / 459 | 34% | 2.53 | 384 / 1118 |
adrenal gland | 73% | 559.07 | 188 / 258 | 11% | 2.22 | 25 / 230 |
lung | 23% | 99.36 | 132 / 578 | 58% | 4.26 | 665 / 1155 |
bladder | 38% | 150.67 | 8 / 21 | 33% | 2.26 | 164 / 504 |
uterus | 26% | 146.85 | 45 / 170 | 43% | 3.58 | 199 / 459 |
tonsil | 0% | 0 | 0 / 0 | 69% | 5.53 | 31 / 45 |
esophagus | 42% | 230.80 | 609 / 1445 | 26% | 1.36 | 47 / 183 |
adipose | 67% | 1124.15 | 804 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 63% | 1985.75 | 584 / 929 | 0% | 0 | 0 / 0 |
pancreas | 4% | 20.59 | 12 / 328 | 51% | 3.41 | 90 / 178 |
stomach | 14% | 52.60 | 50 / 359 | 23% | 1.76 | 67 / 286 |
heart | 34% | 171.31 | 293 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 29% | 197.61 | 383 / 1335 | 0% | 0 | 0 / 0 |
thymus | 15% | 80.86 | 101 / 653 | 11% | 1.02 | 68 / 605 |
liver | 2% | 11.17 | 4 / 226 | 23% | 3.80 | 95 / 406 |
eye | 0% | 0 | 0 / 0 | 9% | 0.34 | 7 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1990539 | Biological process | fructose import across plasma membrane |
GO_0009750 | Biological process | response to fructose |
GO_0106001 | Biological process | intestinal hexose absorption |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_1904659 | Biological process | glucose transmembrane transport |
GO_0003044 | Biological process | regulation of systemic arterial blood pressure mediated by a chemical signal |
GO_0071332 | Biological process | cellular response to fructose stimulus |
GO_0015755 | Biological process | fructose transmembrane transport |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0042383 | Cellular component | sarcolemma |
GO_0070062 | Cellular component | extracellular exosome |
GO_0035579 | Cellular component | specific granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005353 | Molecular function | fructose transmembrane transporter activity |
GO_0070061 | Molecular function | fructose binding |
GO_0005355 | Molecular function | glucose transmembrane transporter activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SLC2A5 |
Protein name | Alternative protein SLC2A5 Solute carrier family 2, facilitated glucose transporter member 5 (Fructose transporter) (Glucose transporter type 5, small intestine) (GLUT-5) Solute carrier family 2 member 5 Solute carrier family 2, facilitated glucose transporter member 5 (Fructose transporter) (Glucose transporter type 5, small intestine) |
Synonyms | GLUT5 |
Description | FUNCTION: Functions as a fructose transporter that has only low activity with other monosaccharides . Can mediate the uptake of 2-deoxyglucose, but with low efficiency . Essential for fructose uptake in the small intestine (By similarity). Plays a role in the regulation of salt uptake and blood pressure in response to dietary fructose (By similarity). Required for the development of high blood pressure in response to high dietary fructose intake (By similarity). . |
Accessions | L8E9T0 ENST00000464985.5 ENST00000486632.5 ENST00000487835.5 ENST00000484798.5 K7EJZ0 ENST00000479813.5 ENST00000377424.9 [P22732-1] K7EQI3 ENST00000377414.7 [P22732-2] P22732 ENST00000474145.5 ENST00000473209.1 K7EIT1 K7EJR1 |